110 related articles for article (PubMed ID: 16306570)
1. A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication.
Ampudia-Blasco FJ; Girbes J; Carmena R
Diabetes Care; 2005 Dec; 28(12):2983. PubMed ID: 16306570
[No Abstract] [Full Text] [Related]
2. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
Holstein A; Stege H; Kovacs P
Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
[TBL] [Abstract][Full Text] [Related]
3. Lipoatrophy with insulin analogues in type I diabetes.
Babiker A; Datta V
Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
Radermecker RP; Piérard GE; Scheen AJ
Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
[TBL] [Abstract][Full Text] [Related]
5. A case of lipoatrophy with human insulin-therapy.
Chantelau E; Reuter M; Schotes S; Starke AA
Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
[TBL] [Abstract][Full Text] [Related]
6. Glargine and lispro: two cases of mistaken identity.
Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
[No Abstract] [Full Text] [Related]
7. The international study of insulin and cancer.
Grimaldi-Bensouda L; Marty M; Pollak M; Cameron D; Riddle M; Charbonnel B; Barnett AH; Boffetta P; Boivin JF; Evans M; Rossignol M; Benichou J; Abenhaim L;
Lancet; 2010 Sep; 376(9743):769-70. PubMed ID: 20816540
[No Abstract] [Full Text] [Related]
8. A possible link between insulin glargine and malignancy: the facts.
Mollentze WF
Cardiovasc J Afr; 2009; 20(4):216-8; discussion 218-9. PubMed ID: 19701528
[No Abstract] [Full Text] [Related]
9. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
[TBL] [Abstract][Full Text] [Related]
11. Insulin glargine.
Am J Health Syst Pharm; 2000 Nov; 57(21):1960-1. PubMed ID: 11094649
[No Abstract] [Full Text] [Related]
12. Effects of mixing glargine and short-acting insulin analogs on glucose control.
Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
[No Abstract] [Full Text] [Related]
13. A case of lipoatrophy with insulin detemir.
Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
[TBL] [Abstract][Full Text] [Related]
14. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
15. Importance of carbohydrate exposure before and after conversion from intravenous insulin therapy to subcutaneous administration of insulin glargine.
Braithwaite SS
Endocr Pract; 2007; 13(2):202-3; author reply 203. PubMed ID: 17494126
[No Abstract] [Full Text] [Related]
16. The use of insulin glargine with gestational diabetes mellitus.
Graves DE; White JC; Kirk JK
Diabetes Care; 2006 Feb; 29(2):471-2. PubMed ID: 16443919
[No Abstract] [Full Text] [Related]
17. Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride.
Standl E; Maxeiner S; Raptis S; Karimi-Anderesi Z; Schweitzer MA;
Diabetes Care; 2005 Feb; 28(2):419-20. PubMed ID: 15677803
[No Abstract] [Full Text] [Related]
18. [Clinical use of long-acting insulin analogs].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
[No Abstract] [Full Text] [Related]
19. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
[No Abstract] [Full Text] [Related]
20. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
Rand J
J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
